GlassScriptPhysician profile
Sohail H Ali
NPI 1235137167
$11,326.11
in general payments reported to CMS, 2019-2025
51 companies · $1,487 in 2025
The $1,487 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,904 · 2020: $3,573 · 2021: $193 · 2022: $182 · 2023: $1,478 · 2024: $1,509 · 2025: $1,487.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,475.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,474.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tandem Diabetes Care, INC. | $3,894.12 | 2019-2024 | T:Slim X2 Insulin Pump With Control-Iq |
| Novo Nordisk INC | $1,034.36 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $791.96 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Radius Health, INC. | $523.87 | 2019-2025 | Tymlos |
| Sanofi-Aventis U.S. LLC | $466.63 | 2019-2025 | |
| Amgen INC. | $433.00 | 2019-2025 | Tepezza, Evenity, Prolia |
| Abbvie INC. | $355.17 | 2019-2025 | Synthroid |
| Boehringer Ingelheim Pharmaceuticals, INC. | $315.11 | 2019-2025 | Jardiance, Synjardy |
| Ibsa Pharma INC. | $305.10 | 2020-2025 | Tirosint, Licart, Tirosint |
| Amneal Pharmaceuticals LLC | $283.78 | 2019-2025 | Unithroid |
| Bayer Healthcare Pharmaceuticals INC. | $187.49 | 2022-2024 | |
| Janssen Pharmaceuticals, INC | $174.43 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $172.24 | 2019-2020 | |
| Insulet Corporation | $160.81 | 2019-2025 | Omnipod |
| Abbott Laboratories | $152.74 | 2019-2020 |
Show all 51 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $141.79 | 2019-2020 | |
| Xeris Pharmaceuticals, INC. | $127.30 | 2020-2025 | Gvoke Hypopen, Recorlev |
| Beta Bionics, INC. | $119.74 | 2023-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $117.99 | 2019-2020 | |
| Cequr Corporation | $116.65 | 2023-2025 | Cequr Simplicity |
| Corcept Therapeutics | $115.28 | 2020-2025 | Korlym |
| Sequel Med Tech, LLC | $107.19 | 2025 | Twiist |
| Dexcom, INC. | $105.34 | 2019-2024 | Dexcom G6 Transmitter |
| Pfizer INC. | $103.12 | 2019-2024 | |
| Shire North American Group INC | $93.58 | 2019 | |
| Amarin Pharma, INC. | $81.81 | 2019 | |
| Antares Pharma, INC. | $70.73 | 2019-2024 | Xyosted |
| Ipsen Biopharmaceuticals, INC | $68.68 | 2019 | |
| Kyowa Kirin, INC. | $68.46 | 2023-2024 | Crysvita |
| Averitas Pharma INC. | $66.79 | 2023-2025 | Qutenza |
| Recordati_rare_diseases_inc. | $59.88 | 2021 | |
| Novartis Pharmaceuticals Corporation | $56.51 | 2025 | |
| Neurocrine Biosciences, INC. | $54.78 | 2024-2025 | |
| Kowa Pharmaceuticals America, INC. | $36.01 | 2019-2020 | |
| Horizon Therapeutics Plc | $33.75 | 2019-2020 | |
| Rhythm Pharmaceuticals, INC. | $32.74 | 2021 | |
| Valeritas, INC. | $28.48 | 2019 | |
| Senseonics, Incorporated | $26.00 | 2019-2020 | |
| Globus Medical, INC. | $24.92 | 2025 | Senza |
| Chiesi USA, INC. | $23.46 | 2025 | Mycapssa |
| Astellas Pharma US INC | $21.46 | 2023 | Veozah |
| Almatica Pharma LLC | $20.77 | 2025 | Teriparatide |
| Amphastar Pharmaceuticals, INC. | $20.46 | 2023 | Baqsimi |
| Ascendis Pharma Endocrinology INC | $19.82 | 2025 | Yorvipath |
| Ascensia Diabetes Care US INC. | $19.14 | 2024 | |
| Halozyme INC | $18.78 | 2023 | |
| Lifescan, INC. | $16.47 | 2023 | |
| Renalytix Ai, INC. | $16.09 | 2023 | Kidneyintelx Blood Collection Convenience Kit |
| Medtronic, INC. | $15.79 | 2023 | Minimed 780g |
| Paratek Pharmaceuticals, INC. | $13.99 | 2025 | Nuzyra |
| Medtronic Minimed, INC. | $11.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sohail Ali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.